Making the invisible visible: A qualitative interview study on the impact of young onset Parkinson’s disease on (ex-)partners
Objective: This study aimed to explore the impact of having an (ex-)partner with young onset Parkinson’s disease (YOPD) on daily life. Background: People with YOPD…Failure of model-based outcome monitoring in Parkinson’s Disease Apathy
Objective: To investigate the neural basis of apathy in Parkinson’s Disease (PD). Background: Apathy is a debilitating and poorly understood syndrome characterised by a reduction…The feasibility of MRI guided focused ultrasound for posttraumatic tremor with prior hemicraniotomy and skull defect
Objective: To assess the feasibility of MRgFUS lesioning in the context of prior hemicraniotomy Background: Targeted stereotactic lesioning, using MRgFUS, is an effective treatment option…Comparing the Connectivity of Thalamic Deep Brain Stimulation Sites in ET and ET Plus Syndrome
Objective: To examine differences in structural connectivity of deep brain stimulation (DBS) sites in patients with essential tremor (ET) and essential tremor plus syndrome (ET-plus).…Altered cognitive control processes in the prodromal phase of X-linked dystonia-parkinsonism (XDP)
Objective: Investigating non-manifesting carriers (NMC) of the TAF1 gene mutation causing X-linked dystonia-parkinsonism to reveal a potential change in the neural basis of cognitive control processes during…Electrophysiological correlates of the increase in rigidity with the Froment maneuver in Parkinson’s patients
Objective: To investigate the physiological basis underlying the increase of rigidity during co-innervation (Froment maneuver) in Parkinson´s disease (PD) patients and to probe whether this…Combined effect of polygenic background and GBA Pathogenic variants in Parkinson’s disease risk
Objective: We aimed to investigate whether polygenic background affects the penetrance of Parkinson’s disease (PD) among carriers of heterozygous pathogenic variants (PV) in GBA. Background: Several rare homozygous mutations within…Parkinson’s disease and Charcot-Marie-Tooth type 2: coincidental or causal?
Objective: To report a patient with Charcot-Marie-Tooth (CMT) type 2N (CMT2N) due to AARS gene mutation who developed early-onset Parkinson’s disease (PD). Background: Aminoacyl tRNA…Chinese medicine pattern diagnostic criteria in clinical and epidemiological studies of Parkinson’s disease: a systematic review
Objective: To summarize the diagnostic criteria of Chinese medicine patterns (CMPs) adopted by clinical and epidemiological studies of Parkinson’s disease (PD). Background: One major reason…Clozapine Therapy for Parkinson’s Disease Psychosis: A 21-Year Service Analysis
Objective: To review the demographic aspects, safety, and efficacy of Clozapine treatment for Parkinson’s Disease Psychosis (PDP) in a large patient cohort. Background: The impact…
- « Previous Page
- 1
- …
- 138
- 139
- 140
- 141
- 142
- …
- 186
- Next Page »